Education
About Us
Working with TipRanks
Follow Us
Silence Therapeutics (SLN)
NASDAQ:SLN
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 43.26M | £ 25.38M | £ 17.50M | £ 12.41M | £ 5.48M |
| Gross Profit | £ 31.45M | £ 15.06M | £ 6.62M | £ 4.96M | £ 1.72M |
| Operating Income | £ -63.32M | £ -49.60M | £ -48.59M | £ -45.81M | £ -35.85M |
| EBITDA | £ -48.99M | £ -49.78M | £ -47.88M | £ -45.42M | £ -35.53M |
| Net Income | £ -45.31M | £ -43.27M | £ -40.49M | £ -39.41M | £ -32.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 147.33M | £ 54.03M | £ 71.14M | £ 73.54M | £ 37.45M |
| Total Assets | £ 202.63M | £ 93.82M | £ 107.50M | £ 96.19M | £ 85.97M |
| Total Debt | £ 117.00K | £ 272.00K | £ 446.00K | £ 137.00K | £ 341.00K |
| Net Debt | £ -121.21M | £ -53.76M | £ -54.37M | £ -73.40M | £ -27.11M |
| Total Liabilities | £ 68.61M | £ 76.77M | £ 85.43M | £ 87.67M | £ 76.91M |
| Stockholders' Equity | £ -134.02M | £ 17.05M | £ 22.07M | £ 8.53M | £ 9.06M |
| Cash Flow | |||||
| Free Cash Flow | £ -67.85M | £ -39.40M | £ -45.90M | £ 5.47M | £ -11.29M |
| Operating Cash Flow | £ -67.64M | £ -39.35M | £ -45.46M | £ 6.81M | £ -10.78M |
| Investing Cash Flow | £ -21.97M | £ 16.43M | £ -16.54M | £ 8.68M | £ 9.62M |
| Financing Cash Flow | £ 142.09M | £ 25.16M | £ 43.05M | £ 30.71M | £ 15.43M |